As for CD8+ T cells, they are generally considered as anti-tumor effectors [42,43], but a contrary result was also reported, whereby more CD8+ T cells were related to an advanced stage of ovarian cancer [62]. The gene discussed is CD8A; the disease is ovarian cancer.